These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9412303)

  • 1. Reversibility of hepatic fibrosis in autoimmune hepatitis.
    Dufour JF; DeLellis R; Kaplan MM
    Ann Intern Med; 1997 Dec; 127(11):981-5. PubMed ID: 9412303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversibility of cirrhosis in chronic hepatitis B.
    Malekzadeh R; Mohamadnejad M; Rakhshani N; Nasseri-Moghaddam S; Merat S; Tavangar SM; Sohrabpour AA
    Clin Gastroenterol Hepatol; 2004 Apr; 2(4):344-7. PubMed ID: 15067631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy.
    Cotler SJ; Jakate S; Jensen DM
    J Clin Gastroenterol; 2001; 32(5):428-30. PubMed ID: 11319316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment.
    Dufour JF; DeLellis R; Kaplan MM
    Dig Dis Sci; 1998 Dec; 43(12):2573-6. PubMed ID: 9881484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis.
    Khonde P; Choudhury S; Spies NC; Naz N; Stoll J; Fleckenstein J; He M; Ballentine S; Kulkarni S
    Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102442. PubMed ID: 39103121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission.
    Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis].
    Valera JM; Smok G; Márquez S; Poniachik J; Brahm J
    Gastroenterol Hepatol; 2011 Jan; 34(1):10-5. PubMed ID: 21194803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
    Mohamadnejad M; Malekzadeh R; Nasseri-Moghaddam S; Hagh-Azali S; Rakhshani N; Tavangar SM; Sedaghat M; Alimohamadi SM
    Dig Dis Sci; 2005 Mar; 50(3):547-51. PubMed ID: 15810640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
    J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis.
    Ferreira AR; Roquete ML; Toppa NH; de Castro LP; Fagundes ED; Penna FJ
    J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):65-70. PubMed ID: 18162836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis.
    Efe C; Cengiz M; Kahramanoğlu-Aksoy E; Yilmaz B; Özşeker B; Beyazt Y; Tanoğlu A; Purnak T; Kav T; Turhan T; Ozenirler S; Ozaslan E; Wahlin S
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):649-54. PubMed ID: 25860719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of cirrhosis in autoimmune hepatitis.
    Malekzadeh R; Mohamadnejad M; Nasseri-Moghaddam S; Rakhshani N; Tavangar SM; Sohrabpour AA; Tahaghoghi S
    Am J Med; 2004 Jul; 117(2):125-9. PubMed ID: 15234650
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis.
    Puustinen L; Boyd S; Mustonen H; Arkkila P; Arola J; Färkkilä M
    Scand J Gastroenterol; 2017 Mar; 52(3):321-327. PubMed ID: 27846740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of autoimmune hepatitis presenting with jaundice.
    Panayi V; Froud OJ; Vine L; Laurent P; Woolson KL; Hunter JG; Madden RG; Miller C; Palmer J; Harris N; Mathew J; Stableforth B; Murray IA; Dalton HR
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):640-5. PubMed ID: 24694760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hepatitis in African Americans: presenting features and response to therapy.
    Lim KN; Casanova RL; Boyer TD; Bruno CJ
    Am J Gastroenterol; 2001 Dec; 96(12):3390-4. PubMed ID: 11774954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.